📍 WASHINGTON D.C., USA
29.10.2026
Federal Health Policy Shift Ignites Surging Demand for Compounded Peptides in the US
A sudden regulatory policy pivot announced by the United States Department of Health and Human Services has triggered an unprecedented surge across the domestic wellness and biopharmaceutical compounding sectors. HHS Sec...